First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity

Autor: Postel-Vinay, Sophie a, b, ∗, Herbschleb, Karin c, Massard, Christophe a, Woodcock, Victoria c, Soria, Jean-Charles a, Walter, Annette O. d, Ewerton, Flavio d, Poelman, Martine e, Benson, Neil f, Ocker, Matthias d, Wilkinson, Gary d, Middleton, Mark c
Zdroj: In European Journal of Cancer March 2019 109:103-110
Databáze: ScienceDirect
Externí odkaz: